News
Roche to invest US$50 billion in US to avoid Trump tariffs, create 12,000 jobs
ZURICH] Roche said on Tuesday (Apr 22) it would invest US$50 billion in the United States over the next five years, creating more than 12,000 new jobs, in the latest massive investment by companies reacting to President Donald Trump’s tariff policy.
Zacks Investment Research on MSN19h
Novartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...
Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...
The United States is a key market for the pharmaceutical industry, representing more than half of the revenue of Roche's ...
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...
Nikki Odum was on vacation with her family when she noticed something unusual — a strange shape under her armpit near her left breast. At 36 years old, this discovery was both unexpected and alarming.
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...
Hikma Pharmaceuticals (OTCPK:HKMPF) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback